Early Detection of Human Papillomavirus–Driven Oropharyngeal Cancer Using Serology From the Study of Prevention of Anal Cancer
Authors:
- 1 November 2020
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 6 (11) , 1806-1808
Abstract
This case series examines HPV seropositivity and antibody levels in a cohort of older men who have sex with men.Keywords
This publication has 6 references indexed in Scilit:
- Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortiumAnnals of Oncology, 2019
- Human Papillomavirus Seroprevalence and Association with Anal HPV Infection and Squamous Intraepithelial Lesions in Australian Gay and Bisexual MenCancer Epidemiology, Biomarkers & Prevention, 2018
- Screening for human papillomavirus‐driven oropharyngeal cancer: Considerations for feasibility and strategies for researchCancer, 2018
- Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal CancerJNCI: Journal of the National Cancer Institute, 2017
- Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinomaInternational Journal of Cancer, 2017
- Multiplex Human Papillomavirus Serology Based on In Situ–Purified Glutathione S-Transferase Fusion ProteinsClinical Chemistry, 2005